Related Experiment Videos
Interferon-gamma protects against biomaterial-associated Staphylococcus epidermidis infection in mice
J J Boelens1, T van der Poll, J Dankert
1Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Boelensjj@yahoo.com
Abstract:
Survival of Staphylococcus epidermidis inside macrophages has been recognized as a pivotal process in the pathogenesis of biomaterial-associated infection (BAI). Interferon (IFN)-gamma is a potent activator of macrophages. This study examined whether subcutaneous injections of IFN-gamma can reverse macrophage deactivation induced by implanted biomaterials. Mice received subcutaneous implants combined with an injection of 106 S. epidermidis to induce an experimental BAI. Subsequently, 3 groups of mice received subcutaneous injections of 25,000 IU IFN-gamma 3 times weekly, 10,000 IU IFN-gamma 3 times in 2 weeks, or saline 3 times weekly (saline control), respectively. A fourth group received no injections (control). Segments and tissues of the IFN-gamma-treated mice were significantly less (P<.05) culture positive than those of the control groups. Histologically, the high numbers of intracellularly persisting gram-positive cocci observed in the control mice were absent in the IFN-gamma-treated mice. These data indicate that IFN-gamma protects against experimental BAI.
Insights
Interferon (IFN)-gamma injections reduced Staphylococcus epidermidis survival within macrophages, offering protection against biomaterial-associated infections. This treatment reversed macrophage deactivation, crucial for combating persistent bacterial infections.
Area of Science:
- Immunology
- Infectious Diseases
- Biomaterials Science
Background:
- Macrophage survival of Staphylococcus epidermidis is key in biomaterial-associated infections (BAI).
- Interferon (IFN)-gamma activates macrophages, potentially counteracting BAI pathogenesis.
Purpose of the Study:
- To investigate if subcutaneous IFN-gamma injections can reverse biomaterial-induced macrophage deactivation.
- To evaluate the efficacy of IFN-gamma in treating experimental biomaterial-associated infections.
Main Methods:
- Mice with S. epidermidis-induced BAI received subcutaneous IFN-gamma or saline injections.
- Bacterial cultures and histological analyses were performed on tissue samples.
- Different dosages and frequencies of IFN-gamma administration were tested.
Main Results:
- IFN-gamma treated mice showed significantly lower bacterial loads in tissues compared to controls.
- Intracellular S. epidermidis was significantly reduced in IFN-gamma treated groups.
- Histology confirmed the absence of high numbers of intracellular bacteria post-treatment.
Conclusions:
- Subcutaneous IFN-gamma administration effectively protects against experimental biomaterial-associated infections.
- IFN-gamma treatment reverses macrophage deactivation, inhibiting intracellular bacterial survival.
- IFN-gamma shows promise as a therapeutic agent for BAI.